학술논문
Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study
Document Type
Article
Author
Source
In The Lancet Regional Health - Western Pacific January 2024 42
Subject
Language
ISSN
2666-6065